VARIOUS FORMS OF MUTANT p53 CONFER SENSITIVITY TO CISPLATIN AND DOXORUBICIN IN BLADDER CANCER CELLS-Reference-Cited by-同舟云学术

VARIOUS FORMS OF MUTANT p53 CONFER SENSITIVITY TO CISPLATIN AND DOXORUBICIN IN BLADDER CANCER CELLS

Published:2001-07 Issue:1 Volume:166 Page:304-310
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

CHANG FU-LIN¹,LAI MING-DERG¹

Affiliation:

1. From the Department of Biochemistry, College of Medicine, National Cheng Kung University and Department of Industrial Safety and Hygiene, Chung Hwa Institute of Technology, Tainan, Taiwan, Republic of China

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference26 articles.

1. p53 Function and dysfunction;Vogelstein;Cell,1992

2. p53, the cellular gatekeeper for growth and division;Levine;Cell,1997

3. p53 From inductive signal to cellular effect;Hansen;Curr Opin Genet Dev,1997

4. p53 and apoptosis;Gottlieb;Semin Cancer Biol,1998

5. p53 Mutations in human cancer;Hollstein;Science,1991

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GABBR2 as a Downstream Effector of the Androgen Receptor Induces Cisplatin Resistance in Bladder Cancer;International Journal of Molecular Sciences;2023-09-06

2. Progress in the development of tissue-based biomarkers for urothelial cancer;Expert Review of Anticancer Therapy;2022-04-29

3. Efficacy of Incremental Next-Generation ALK Inhibitor Treatment in Oncogene-Addicted, ALK-Positive, TP53-Mutant NSCLC;Journal of Personalized Medicine;2020-08-28

4. Characterization of p53 Family Homologs in Evolutionary Remote Branches of Holozoa;International Journal of Molecular Sciences;2019-12-18

5. Significance of TP53 mutation in bladder cancer disease progression and drug selection;PeerJ;2019-12-16